|
|
| (11) | Number of the document | C 2178888 |
| (68) | Number of the document | 2178888 |
| (21) | Application number for Supplementary Protection Certificate | PA 2017 010 |
| (22) | Date of filing the application | 2017-04-06 |
| (41) | Date of publication of the application | 2017-05-10 |
| Date of publication of SPC | 2018-03-12 | |
| (24) | Date of coming into effect of SPC | 2027-08-07 |
| (71) |
Millennium Pharmaceuticals, Inc.,
40 Landsdowne Street, Cambridge, MA 02139,
US
|
| (73) |
Takeda Pharmaceutical Company Limited ,
1-1, Doshomachi 4-chome, Chuo-ku, Osaka 540-8645,
JP
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (93) | EU/1/16/1094, 2016-11-21 |
| (94) | 2031-11-23 |
| (95) | Iksazomibas arba jo farmaciniu požiūriu priimtina druska ir esteris, toks kaip iksazomibo citratas |
| SPC granted |